HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.

Abstract
Treatment of glioblastoma (GBM) remains to be the most formidable challenge because of the hindrance of the blood-brain barrier (BBB) along with the poor drug penetration into the glioma parenchyma. Nanoparticulate drug delivery systems (DDS) utilizing transferrin (Tf) as the targeting ligand to target the glioma-associated transferrin receptor (TfR) had met the problem of loss of specificity in biological environment due to the high level of endogenous Tf. Here we conjugated CRT peptide, an iron-mimicry moiety targeting the whole complex of Tf/TfR, to poly(ethylene glycol)-poly(l-lactic-co-glycolic acid) nanoparticles (CRT-NP), to open a new route to overcome such obstacle. High cellular associations, advanced transport ability through the BBB model, and penetration in 3-dimensional C6 glioma spheroids in vitro had preliminarily proved the advantages of CRT-NP over Tf-nanoparticle conjugates (Tf-NP). Compared with Tf-NP, NP, and Taxol, paclitaxel-loaded CRT-NP (CRT-NP-PTX) displayed a superior antiproliferation effect on C6 glioma cells and stronger inhibitory effect on glioma spheroids. Favored pharmacokinetics behavior and enhanced accumulation in glioma foci was observed, together with a much deeper distribution pattern in glioma parenchyma compared with unmodified nanoparticles and Tf-NP. Eventually, mice treated with CRT-NP-PTX showed a remarkably prolonged median survival compared to those treated with Taxol, NP, or Tf-NP. In conclusion, the modification of CRT to nanoparticles holds great promise for enhancement of antiglioma therapy.
AuthorsTing Kang, Mengyin Jiang, Di Jiang, Xingye Feng, Jianhui Yao, Qingxiang Song, Hongzhuan Chen, Xiaoling Gao, Jun Chen
JournalMolecular pharmaceutics (Mol Pharm) Vol. 12 Issue 8 Pg. 2947-61 (Aug 03 2015) ISSN: 1543-8392 [Electronic] United States
PMID26149889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • CD71 antigen
  • Peptide Fragments
  • Receptors, Transferrin
  • Transferrin
  • Polyethylene Glycols
  • Iron
  • Paclitaxel
Topics
  • Animals
  • Antigens, CD (metabolism)
  • Apoptosis (drug effects)
  • Blood-Brain Barrier (drug effects, metabolism)
  • Brain (cytology, drug effects, metabolism)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Drug Delivery Systems
  • Glioblastoma (drug therapy, metabolism, pathology)
  • Iron (pharmacology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (administration & dosage, chemistry)
  • Paclitaxel (administration & dosage)
  • Peptide Fragments (pharmacology)
  • Photoelectron Spectroscopy
  • Polyethylene Glycols (chemistry)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Transferrin (antagonists & inhibitors, metabolism)
  • Tissue Distribution
  • Transferrin (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: